RPRichard Bayley Paisey

Richard Bayley Paisey

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Richard Bayley Paisey has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Editorial: Improving outcomes in diabetic foot care - a worldwide perspective

    by Richard Paisey, José Luis Lázaro Martínez, Frances Game, Honda Hsu, Joanne Paton

    The International Diabetes Federation has documented the challenging increase in prevalence of diabetes mellitus now evident in virtually every country in the world [1] . Over 90% have type 2 diabetes, and the majority of those living with diabetes live in low-or middle-income countries [2]. The specific diabetes associated complications-retinopathy, nephropathy and neuropathy are compounded by the enhanced risk of atherosclerotic vascular disease. Peripheral neuropathy, peripheral vascular disease and susceptibility to infection result in a high incidence of diabetic foot disease manifested by foot deformity, ulceration, ischaemia and infection [3]. The intractable nature of diabetic foot disease severely affects the quality of life and survival of those affected, impacts livelihood and family life and incurs enormous health care costs [4]. The incidences and outcomes for diabetic foot disease are influenced by age, ethnicity, deprivation and availability of early diagnosis and treatments [5,6].In this research topic we have sought to collate a worldwide perspective to encourage sharing of differing approaches to diabetic foot care and cross-cultural debate. We have been privileged to receive manuscripts from high-, middle-and low-income countries, which have provided insights into-assessment of strategies to prevent and heal foot ulceration; risk factors for foot ulceration; morbidity and mortality; established and novel treatment options.The key to prevention of diabetic foot wounds in high-risk subjects lies with patient engagement, and the group from Malaga assess the reliability and validity of a selfmanagement questionnaires. The Birmingham group have shown that individuals with newonset type 2 diabetes who had moderate to high risk of diabetic foot disease were more likely to die compared to those at low risk. Those who did not have foot examination had high risk both of foot ulceration and mortality. A review of wound healing from China offers hope that better preparation of exosomes could help healing in diabetic foot wounds. A metanalysis from India tackles the important issue of micronutrient deficiencies in Diabetic foot ulcer patients. Articles from Indigenous peoples in Canada and Nepal emphasise the need for a holistic approach to patient care and antimicrobial stewardship is evaluated in Peru. Dressings and debridement are reviewed in articles from Guizou in China and the intricacies of total contact casting versus removable casts and footwear in another metanalysis. From Chengdu in China another tackles the issue of standard versus advanced methods of debridement. Ozone therapy, platelet rich plasma application for DFU and micronutrient status in DFU are also presented. A single centre study from the UK highlights the value of national and local data analysis which has shown worse outcomes for diabetic foot disease in deprived populations during the Covid-19 epidemic. Finally, an important surgical report of distally based sural neurocutaneous flaps in severe foot wounds has shown considerable success with good healing and subsequent excellent patient mobility.The scope of these articles is wide, highlighting the need for more insights from around the world, to share innovations to help reduce the incidence and improve outcomes in diabetic foot disease.

  • Open Access

    Body weight, diabetes incidence vascular events and survival 15 years after very low calorie diet in community medical clinics in the UK

    by Richard Paisey, Charles Daniels, Will Howitt, Derek Greatorex, Claire Campbell, Christopher Paisey, Rosamund Paisey, Julie Frost, Robert Bromige

    Objective: To assess weight loss maintenance, diabetes status, mortality and morbidity 15 years after a very low calorie diet programme (VLCD) in patients with obesity. Design: General practice data bases were interrogated for subjects coded for group therapy with VLCD in the 1990s. Causes of death, occurrence of vascular disease and remission or development of diabetes were ascertained from patient records and national stroke and cardiovascular disease data bases. Results: 325 subjects engaged in the programme and had sufficient data for analysis. Baseline characteristics were: age 47.8±12. 8 years; body mass index (BMI) 36.1±6.8 kg/m 2 ; 79.1% female/20.9% male; 13.5% had type 2 diabetes. After 15±4 years weight had changed from 97.9±19 kg at baseline to 100±20.8 kg. 10 with diabetes at baseline were in remission at 3 months, but only two remained in remission at 5 years. 50 new cases of type 2 diabetes and 11 of impaired fasting glucose developed during follow-up. Only 5.9% who remained healthy at follow-up had maintained >10% body weight reduction. Neither diabetes incidence nor diabetes free survival were related to percentage body weight lost during VLCD. Only baseline BMI was related to development of new impaired fasting glucose or diabetes by 15 years (p=0.007). 37 subjects had a cardiovascular event. Age (p=0.000002) and degree of weight loss after VLCD (p=0.03) were significantly associated with subsequent vascular events. Conclusion: Long-term maintenance of weight loss after VLCD was rare in this single centre retrospective study 15 years later. Glucose intolerance developed in 21.4%. Lasting remission of type 2 diabetes or prevention of later glucose intolerance were not achieved. Vascular events were more frequent in those who lost most weight. Risk management during weight regain should be studied in future to assess potential for reduction in adverse cardiovascular outcomes.


  • Open Access

    Service user and community clinician design of a partially virtual diabetic service improves access to care and education and reduces amputation incidence

    by Alastair Watt, Andrea Beacham, Lynne Palmer-Mann, Amy Williams, Jacqueline White, Rebecca Brown, Ellena Williams, Gayle Richards, Lyndon White, Pauline Budge, et al.

    Introduction Design of an integrated diabetes service based on needs of service users (persons living with diabetes) and community clinicians in a semirural low-income health district of the UK. Research design and methods One hundred and eighty-five service users engaged through public meetings, questionnaires and focus groups. General practice staff contributed views through workshops and questionnaires. Analysis of feedback indicated service user needs for better access to education, dietary advice and foot care. General practice staff endorsed these views and requested regular access to secondary care in the community. Seven hundred persons registered with diabetes attended eight well-being events in the community. From 2017 virtual practice multidisciplinary patient reviews, virtual referral of foot cases and non-face-to-face helplines were developed. A National Health Service (NHS) approved ‘App’ and web-based personalized education support for those recently diagnosed with diabetes was introduced. Results Engagement in education for those recently diagnosed with diabetes increased from 5% to 71%. Weight and hemoglobin A1c (HbA1c) levels before and 6 months after starting the program were 99.4±25 and 95.5±24.2 kg and 59.3±16 and 54.8±12.9 mmol/mol, respectively, p=0.00003 and 0.003. Of those engaging at well-being events, 44 had missed regular follow-up. One hundred and seventy-five cases were reviewed virtually with practice staff by the secondary care team avoiding referral to the hospital diabetic clinic. One hundred and seventy-six referrals were made to the virtual multidisciplinary diabetic foot team clinic. Major amputation incidence declined from 13 to 3 major procedures/10 000 per annum and minor amputation from 26 to 18/10 000. Percentage bed day occupancy by persons with diabetes fell significantly in the district general hospital. Conclusions Integrated community-based diabetes care delivery has been achieved with partially virtual reviews. Patient education, secondary care in the community, access to dietetic advice and foot care outcomes have all improved.


  • Open Access

    Diabetic foot ulcer incidence and survival with improved diabetic foot services: an 18‐year study

    by R. B. Paisey, A. Abbott, C. F. Paisey, D. Walker

    Aims: To ascertain the effects of improvements in diabetic foot services over 18 years on incidence of diabetic foot ulceration. We also compared survival time from first ulcer development with presence of neuropathy, peripheral vascular disease, age and healing.Methods: Persons with new ulceration and those at high risk of ulcer development were referred to community podiatry from 1998. Their details were recorded, with verbal consent, on a central database. The effects of neuropathy, peripheral vascular disease, healing and age on survival were analysed by Cox proportional hazards ratios.Results: The incidence of first ulcer presentation decreased from 11.1 to 6.1 per 1000 persons between 2003 to 2017 (P P P <0.001).Conclusions: Integrated care for the diabetic foot in one National Health Service (NHS) health service area over 18 years was associated with a reduction in first presentations of diabetic foot ulceration, but failed to reduce recurrent ulceration. Cumulative prevalence of all ulcers continues to increase. Monitoring ulceration incidence can inform audit and planning of diabetic foot care services. Survival is better than reported previously in persons < 65 years and in the absence of peripheral vascular disease.


  • Open Access

    Diabetes‐related major lower limb amputation incidence is strongly related to diabetic foot service provision and improves with enhancement of services: peer review of the South‐West of England

    by R. B. Paisey, A. Abbott, R. Levenson, A. Harrington, D. Browne, J. Moore, M. Bamford, M. Roe, the South‐West Cardiovascular Strategic Clinical Network peer diabetic foot service review team

    Aims: To investigate the relationship between high diabetes‐related lower limb amputation incidence and foot care services in the South‐West region of England.Methods: The introduction of 10 key elements of foot care service provision in one area of the South‐West resulted in stabilization of foot ulcer incidence and sustained reduction in amputation incidence from 2007. Services introduced included administrative support, standardized general practice foot screening, improved community podiatry staffing, hospital multidisciplinary foot clinics, effective care pathways, availability of an orthotist and audit. Peer reviews of the region's diabetes foot care services were undertaken to assess delivery of these service provisions and compare this with major amputation incidence in other regions with data provided by Yorkshire and Humber Public Health Observatory Hospital Episode Statistics. Recommendations were made to improve service provision. In 2015 changes in service provision and amputation incidence were reviewed.Results: Initial reviews in 2013 showed that the 3‐year diabetes‐related major amputation incidence correlated inversely with adequate delivery of diabetes foot care services (P=0.0024, adjusted R2 =0.51). Repeat reviews in 2015 found that two or more foot care service improvements were reported by six diabetes foot care providers, with improvement in outcomes. The negative relationship between major amputation incidence and service provision remained strong both in the period 2012–2015 and in the year 2015 only (P ≤0.0012, adjusted R2 =0.56, and P= 0.0005, R2=0.62, respectively).Conclusions: Major diabetes‐related lower limb amputation incidence is significantly inversely correlated with foot care services provision. Introduction of more effective service provision resulted in significant reductions in major amputation incidence within 2 years. Failure to improve unsatisfactory service provision resulted in continued high amputation incidence.


  • Current management of Alström syndrome and recent advances in treatment

    by R. B. Paisey, K. Leeson-Beevers

    Introduction: Alström syndrome is a recessively inherited condition (OMIM 203800) characterised by dual sensory loss, type 2 diabetes, coronary artery disease, organ fibrosis, and smooth muscle dysfunction. Areas covered: This paper covers family support, educational needs, cardiomyopathy, blindness, deafness, metabolic syndrome, diabetes, smooth muscle dysfunction, hepatic and renal fibrosis. Sources of data include multidisciplinary clinic audits, a research database, Alström Syndrome International clinics, PubMed and Embase searches. Expert opinion: A single intervention to prevent or reverse all manifestations of Alström syndrome is not currently possible. Multidisciplinary annual review is essential to plan treatments and intervene early to treat complications. Braille, IT skills and digital hearing aids are crucial to support education and social integration. Lifestyle modification will prevent type 2 diabetes and mitigate metabolic syndrome and coronary artery disease. Renal transplantation is safe. Hepatic cirrhosis, oesophageal reflux and bladder dystonia are treated as in the general population. Multiple organ dysfunction confers a high risk of death from pneumonia and post-operative hypoxia. Therefore influenza and pneumococcus vaccinations are strongly recommended. Intensive care after all invasive procedures and for infant cardiomyopathy is crucial. Exploration of new therapies to slow retinal degeneration and organ fibrosis is at an early stage.


  • Open Access

    Prediction of protective sensory loss, neuropathy and foot ulceration in type 2 diabetes

    by R B Paisey, T Darby, A M George, M Waterson, P Hewson, C F Paisey, M P Thomson

    Objectives To prospectively determine clinical and biochemical characteristics associated with the development of peripheral neuropathy, loss of protective sensation, and foot ulceration in persons with type 2 diabetes mellitus (DM) over 7 years. Research design and methods Graded monofilament (MF) testing, vibration perception threshold, and neuropathy symptom questionnaires were undertaken in 206 participants with type 2 DM without peripheral vascular disease or history of foot ulceration and 71 healthy participants without DM at baseline and after 7 years. 6 monthly glycosylated hemoglobin (HbA1c) levels and annual serum lipid profiles were measured during follow-up of those with DM. Incident foot ulceration was recorded at follow-up. Results Taller stature and higher quartiles of serum triglyceride and HbA1c levels were associated with neuropathy at follow-up (p=0.008). Remission of baseline neuropathy was observed in 7 participants at follow-up. 9 participants with type 2 DM developed foot ulcers by the end of the study, only 1 at low risk. Mean HbA1c levels were higher in those who developed foot ulceration (pConclusions Tall stature and worse metabolic control were associated with progression to neuropathy. Mean HbA1c levels were higher in those who developed foot ulcers. Graded MF testing may enrich recruitment to clinical trials and assignation of high risk for foot ulceration.


  • Open Access

    Duration of Diabetes Predicts Aortic Pulse Wave Velocity and Vascular Events in Alström Syndrome

    by Richard B. Paisey, Jamie Smith, Catherine Carey, Timothy Barrett, Fiona Campbell, Pietro Maffei, Jan D. Marshall, Christopher Paisey, Richard P. Steeds, Nicola C. Edwards, et al.

    Context: Alström syndrome is characterized by increased risk of cardiovascular disease from childhood. Objective: To explore the association between risk factors for cardiovascular disease, aortic pulse wave velocity, and vascular events in Alström syndrome. Design: Cross-sectional analyses with 5-year follow-up. Setting: The UK NHS nationally commissioned specialist clinics for Alström syndrome. Patients: Thirty-one Alström patients undertook vascular risk assessment, cardiac studies, and aortic pulse wave velocity measurement. Subsequent clinical outcomes were recorded. Interventions: Insulin resistance was treated with lifestyle intervention and metformin, and diabetes with the addition of glitazones, glucagon-like peptide 1 agonists, and/or insulin. Thyroid and T deficiencies were corrected. Dyslipidemia was treated with statins and nicotinic acid derivatives. Cardiomyopathy was treated with standard therapy as required. Main Outcome Measures: The associations of age, gender, and risk factors for cardiovascular disease with aortic pulse wave velocity were assessed and correlated with the effects of reduction in left ventricular function. Vascular events were monitored for 5 years. Results: Aortic pulse wave velocity was positively associated with the duration of diabetes (P = .001) and inversely with left ventricular ejection fraction (P = .036). Five of the cohort with cardiovascular events had higher aortic pulse wave velocity (P = .0247), and all had long duration of diabetes. Conclusions: Duration of diabetes predicted aortic pulse wave velocity in Alström syndrome, which in turn predicted cardiovascular events. This offers hope of secondary prevention because type 2 diabetes can be delayed or reversed by lifestyle interventions.


  • Modification of severe insulin resistant diabetes in response to lifestyle changes in Alström syndrome

    by Richard B. Paisey, Tarekeng Geberhiwot, Michael Waterson, Robert Cramb, Rick Steeds, Kathleen Williams, Alison White, Carol Hardy